These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Monitoring an unstable heart. Implantable cardioverter-defibrillators. Mayo Clin Health Lett; 2006 Jun; 24(6):1-3. PubMed ID: 16830395 [No Abstract] [Full Text] [Related]
3. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Proclemer A; Ghidina M J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096 [No Abstract] [Full Text] [Related]
5. Ventricular tachycardia and ventricular fibrillation. Srivathsan K; Ng DW; Mookadam F Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):801-9. PubMed ID: 19589116 [TBL] [Abstract][Full Text] [Related]
6. Randomized clinical trials: how long should they last? Wellens HJ Circulation; 2004 Jul; 110(2):107-8. PubMed ID: 15249514 [No Abstract] [Full Text] [Related]
7. Driving after ventricular arrhythmias. Smith TW N Engl J Med; 2001 Aug; 345(6):451-2. PubMed ID: 11496857 [No Abstract] [Full Text] [Related]
8. Programmed ventricular stimulation: how low (with the coupling interval) and aggressive (with the protocol) should we go? No easy answers. Haim M; Strasberg B Isr Med Assoc J; 2009 Sep; 11(9):552-4. PubMed ID: 19960850 [No Abstract] [Full Text] [Related]
9. Antitachycardia pacing for ventricular tachycardia using implantable cardioverter defibrillators: Sweeney MO Pacing Clin Electrophysiol; 2004 Sep; 27(9):1292-305. PubMed ID: 15461721 [No Abstract] [Full Text] [Related]
10. Overcoming the defects of a virtue: dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Sweeney MO Circulation; 2006 Jun; 113(25):2862-4. PubMed ID: 16801472 [No Abstract] [Full Text] [Related]
11. Driving and implantable cardioverter-defibrillators a clearer view. Grubb BP J Am Coll Cardiol; 2007 Dec; 50(23):2241-2. PubMed ID: 18061072 [No Abstract] [Full Text] [Related]
12. [Use of implantable cardioverter defibrillators in the secondary prevention of malignant ventricular arrhythmias: lessons from large studies]. Anadolu Kardiyol Derg; 2001 Mar; 1(1):43-7, AXIV. PubMed ID: 12132492 [TBL] [Abstract][Full Text] [Related]
13. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). ; ; Zipes DP; Camm AJ; Borggrefe M; Buxton AE; Chaitman B; Fromer M; Gregoratos G; Klein G; Moss AJ; Myerburg RJ; Priori SG; Quinones MA; Roden DM; Silka MJ; Tracy C; Smith SC; Jacobs AK; Adams CD; Antman EM; Anderson JL; Hunt SA; Halperin JL; Nishimura R; Ornato JP; Page RL; Riegel B; Priori SG; Blanc JJ; Budaj A; Camm AJ; Dean V; Deckers JW; Despres C; Dickstein K; Lekakis J; McGregor K; Metra M; Morais J; Osterspey A; Tamargo JL; Zamorano JL; ; ; J Am Coll Cardiol; 2006 Sep; 48(5):e247-346. PubMed ID: 16949478 [No Abstract] [Full Text] [Related]
14. Primary prevention of sudden cardiac death: one step forwards and one step backwards. Cain ME Nat Clin Pract Cardiovasc Med; 2006 Mar; 3(3):115. PubMed ID: 16505838 [No Abstract] [Full Text] [Related]